135 related articles for article (PubMed ID: 31781299)
1. Genetic Polymorphisms Associated with Thrombotic Disease Comparison of Two Territories: Myocardial Infarction and Ischemic Stroke.
Isordia-Salas I; Martínez-Marino M; Alberti-Minutti P; Ricardo-Moreno MT; Castro-Calvo R; Santiago-Germán D; Alvarado-Moreno JA; Calleja-Carreño C; Hernández-Juárez J; Leaños-Miranda A; Majluf-Cruz A
Dis Markers; 2019; 2019():3745735. PubMed ID: 31781299
[TBL] [Abstract][Full Text] [Related]
2. Platelet glycoprotein IIIA PIA1/A2 polymorphism in young patients with ST elevation myocardial infarction and idiopathic ischemic stroke.
Rivera-García BE; Esparza-García JC; Aceves-Chimal JL; Leaños-Miranda A; Majluf-Cruz A; Isordia-Salas I
Mol Cell Biochem; 2013 Dec; 384(1-2):163-71. PubMed ID: 24005535
[TBL] [Abstract][Full Text] [Related]
3. Association between the Thr325Ile polymorphism of the thrombin-activatable fibrinolysis inhibitor and stroke in the Ludwigshafen Risk and Cardiovascular Health Study.
Kozian DH; Lorenz M; März W; Cousin E; Mace S; Deleuze JF
Thromb Haemost; 2010 May; 103(5):976-83. PubMed ID: 20216989
[TBL] [Abstract][Full Text] [Related]
4. TAFI gene polymorphisms in patients with cerebral venous thrombosis.
Tokgoz S; Zamani AG; Durakbasi-Dursun HG; Yilmaz O; Ilhan N; Demirel S; Tavli M; Sinan A
Acta Neurol Belg; 2013 Sep; 113(3):291-7. PubMed ID: 23264082
[TBL] [Abstract][Full Text] [Related]
5. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
[TBL] [Abstract][Full Text] [Related]
6. Gene polymorphisms of angiotensin-converting enzyme and angiotensinogen and risk of idiopathic ischemic stroke.
Isordia-Salas I; Santiago-Germán D; Cerda-Mancillas MC; Hernández-Juárez J; Bernabe-García M; Leaños-Miranda A; Alvarado-Moreno JA; Majluf-Cruz A
Gene; 2019 Mar; 688():163-170. PubMed ID: 30521887
[TBL] [Abstract][Full Text] [Related]
7. Identification of genetic risk factors associated with ischaemic stroke in young Mexican patients.
Jiménez-González MC; Santiago-Germán D; Castillo-Henkel EF; Alvarado-Moreno JA; Hernández-Juárez J; Leaños-Miranda A; Majluf-Cruz A; Isordia-Salas I
Neurologia (Engl Ed); 2021 Jun; 36(5):337-345. PubMed ID: 34714231
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.
Tàssies D; Roqué M; Monteagudo J; Martorell T; Sionis A; Arzamendi D; Heras M; Reverter JC
Thromb Res; 2009 Nov; 124(5):614-8. PubMed ID: 19699511
[TBL] [Abstract][Full Text] [Related]
9. Plasma thrombin-activatable fibrinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients.
Kamal HM; Ahmed AS; Fawzy MS; Mohamed FA; Elbaz AA
Acta Cardiol; 2011 Aug; 66(4):483-8. PubMed ID: 21894805
[TBL] [Abstract][Full Text] [Related]
10. The impact of single nucleotide polymorphisms of the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI antigen levels in healthy children and pediatric oncology patients.
Knoefler R; Ludwig K; Kostka H; Kuhlisch E; Siegert G; Suttorp M
Semin Thromb Hemost; 2003 Dec; 29(6):575-83. PubMed ID: 14719174
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in the thrombin-activatable fibrinolysis inhibitor gene and risk of cardiovascular disease: a systematic review and meta-analysis.
Shi J; Zhi P; Chen J; Wu P; Tan S
Thromb Res; 2014 Sep; 134(3):610-6. PubMed ID: 25042727
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study.
Fawzy MS; Mohammed EA; Ahmed AS; Fakhr-Eldeen A
Meta Gene; 2015 Jun; 4():73-84. PubMed ID: 25893174
[TBL] [Abstract][Full Text] [Related]
13. Genetic Variants Associated with High Susceptibility of Premature Ischemic Stroke.
Isordia-Salas I; Santiago-Germán D; Jiménez-Alvarado RM; Leaños-Miranda A
J Renin Angiotensin Aldosterone Syst; 2023; 2023():9002021. PubMed ID: 38025202
[TBL] [Abstract][Full Text] [Related]
14. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
Juhan-Vague I; Morange PE; Aubert H; Henry M; Aillaud MF; Alessi MC; Samnegård A; Hawe E; Yudkin J; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):867-73. PubMed ID: 12006404
[TBL] [Abstract][Full Text] [Related]
15. Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer.
Chengwei X; Xiaoli M; Yuan Z; Li P; Shengjiang W; Chao Y; Yunshan W
Blood Coagul Fibrinolysis; 2013 Oct; 24(7):698-703. PubMed ID: 23624357
[TBL] [Abstract][Full Text] [Related]
16. TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study.
Morange PE; Tregouet DA; Frere C; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Cambien F; Tiret L; Juhan-Vague I;
J Thromb Haemost; 2005 Jul; 3(7):1503-10. PubMed ID: 15978108
[TBL] [Abstract][Full Text] [Related]
17. GLU298ASP and 4G/5G Polymorphisms and the Risk of Ischemic Stroke in Young Individuals.
Esparza-García JC; Santiago-Germán D; Guadalupe Valades-Mejía M; Hernández-Juárez J; Aguilar-Sosa E; Leaños-Miranda A; Alvarado-Moreno A; Majluf-Cruz A; Isordia-Salas I
Can J Neurol Sci; 2015 Sep; 42(5):310-6. PubMed ID: 26036781
[TBL] [Abstract][Full Text] [Related]
18. C677T polymorphism of the 5,10 MTHFR gene in young Mexican subjects with ST-elevation myocardial infarction.
Isordia-Salas I; Trejo-Aguilar A; Valadés-Mejía MG; Santiago-Germán D; Leaños-Miranda A; Mendoza-Valdéz L; Jáuregui-Aguilar R; Borrayo-Sánchez G; Majluf-Cruz A
Arch Med Res; 2010 May; 41(4):246-50. PubMed ID: 20637366
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis].
González FJ; Caturla JM; Fernández M; Carrasco R; Marco P; Sánchez J; Benlloch S
Med Intensiva; 2010 Nov; 34(8):513-22. PubMed ID: 20627371
[TBL] [Abstract][Full Text] [Related]
20. Influence of renin-angiotensin system gene polymorphisms on the risk of ST-segment-elevation myocardial infarction and association with coronary artery disease risk factors.
Konopka A; Szperl M; Piotrowski W; Roszczynko M; Stępińska J
Mol Diagn Ther; 2011 Jun; 15(3):167-76. PubMed ID: 21657802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
